Not checked for notices yet.
Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity
Yu Fu, Qing Lin, Zhirong Zhang and 1 more
Acta Pharmaceutica Sinica B · 2020
doi:10.1016/j.apsb.2019.08.010
Cited by papers we hold 6
- Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders · 2024Corrected
- Regulatory cells and the effect of cancer immunotherapy · 2023No notice
- Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response · 2022No notice
- Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives · 2021No notice
- Signal pathways of melanoma and targeted therapy · 2021No notice
- Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.